RPT-1G

N/A

Report date: 2026/03/21 20:00:21
First In Class

Base Information

Drug NameRPT-1G
Drug Alias NameRPT1GRPT-1G
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors
TargetsNicotinamide phosphoribosyltransferase
Therapy Area/IndicationsAutoimmune DiseasesObesityMyelodysplastic Syndromes +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRemedy Plan Therapeutics
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesObesityMyelodysplastic Syndromes +[4
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A